Analysis: Vaccine joy sparks share price snakes and ladders

Virus graph

Global stock markets soared after it was revealed on Monday that pharmaceutical developers Pfizer and BioNTech had successfully completed trials of a coronavirus vaccine in six countries, proving it to be 90% effective.

With the prospect of restrictions easing over the coming months, some of the darling stocks of the pandemic saw their luck turn, while other struggling companies returned to favour.

 

Already have an account?

Want to read more?

Register for LIMITED guest access

Register now

Get premium access

£5 A MONTH for 3 months

Subscribe now